Figure 4.
Analysis of binding between rhodamine B-labeled liposomes and breast cancer cells using flow cytometry. BT-474 and MDA-MB-231 cells were treated with control, ScrErbB2Lipo, and ErbB2Lipo. (A) Plots of flow cytometry results and (B) quantitative analysis of Figure 4A.
